ICVS
Hospitals & Physicians Clinics · Japan · 11-50 Employees
View Company Info for Free
Overview
Headquarters
bldg 4f 4-1 Kioi-cho, Tokyo, Tokyo, Japa...Phone Number
+81 332220551Website
www.icv-s.orgRevenue
$14.8 MillionIndustry
About ICVS
Is ICVS your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once ICVS has new funding data
Website visits: Recent activity has been detected on your website
Click to see if ICVS had a recent Job posting/layoffs
Earning: See what the market has to say on ICVS recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
ICVS, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if ICVS is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at ICVS
Product Launch: Get notified when ICVS launches new products
Check if ICVS has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined ICVS as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
ICVS is experiencing very low activity levels compared to other companies in the Hospitals & Physicians Clinics sector.
What does this means?
ICVS is drawing exceptional interest within the Hospitals & Physicians Clinics industry, suggesting notable developments or strong market momentum, learn more about ICVS.
ICVS Tech Stack
A closer look at the technologies used by ICVS
Top Hospitals & Physicians Clinics Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ICVS
ICVS Tokyo Clinic specializes in cancer immunotherapy, particularly the HITV therapy, which utilizes dendritic cells to enhance the immune response against cancer cells. The clinic aims to provide personalized treatment plans based on advanced techniques and extensive experience in the field. It caters to patients suffering from stage IV and recurr... Read More